Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank67
3Y CAGR+33.2%
5Y CAGR+25.5%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+33.2%/yr
Annual compound
5Y CAGR
+25.5%/yr
Recent acceleration
Percentile
P67
Within normal range
vs 5Y Ago
3.1x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $129.88M | -42.1% |
| 2024 | $224.25M | +75.1% |
| 2023 | $128.10M | +133.3% |
| 2022 | $54.91M | -84.1% |
| 2021 | $346.07M | +729.9% |
| 2020 | $41.70M | +595.6% |
| 2019 | $6.00M | - |